James was Board Director at Zogenix, and Director at Otonomy.
James Breitmeyer is currently President and Chief Executive Officer at Oncternal Therapeutics - View - Oncternal Therapeutics org chart
Create your alert
to follow the career of James Breitmeyer.
James Breitmeyer has a Bachelor in Chemistry and Biology from University of California, Santa Cruz and a PhD in Medicine and Immunology from Washington University School of Medicine in St. Louis.
They have also studied at University of California, Santa Cruz :
Find more alumni from University of California, Santa Cruz
Do you need to know more about James Breitmeyer? More results.
Report an error
Update the org chart details of James Breitmeyer.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.